Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a

Biochemical and Biophysical Research Communications

Volumn 463, Issue 4, 2015, Pages 1278-1283

  Kobayashi, Yasuhiro ^a   Thirukonda, Gnanasagar J ^a   Nakamura, Yukio ^b   Koide, Masanori ^a   Yamashita, Teruhito ^a   Uehara, Shunsuke ^a   Kato, Hiroyuki ^b   Udagawa, Nobuyuki ^a   Takahashi, Naoyuki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone resorbing activity; Osteoclasts; Osteoprotegerin; Wnt16; Wnt4; Wnt5a

Indexed keywords

CALCITRIOL; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; WNT PROTEIN; WNT16 PROTEIN; WNT3A PROTEIN; WNT4 PROTEIN; WNT5A PROTEIN; OSTEOPROTEGERIN; WNT16 PROTEIN, MOUSE; WNT5A PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED MACROPHAGE; COCULTURE; CORTICAL BONE; DENTIN SLICE; MACROPHAGE CULTURE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRABECULAR BONE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; PHYSIOLOGY;

MUS;

ANIMALS; CALCITRIOL; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; MICE; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOPROTEGERIN; WNT PROTEINS;

EID: 84940460087     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.06.102     Document Type: Article

References (31)

1. S.L. Teitelbaum, and F.P. Ross Genetic regulation of osteoclast development and function Nat. Rev. Genet. 4 2003 638 649
2. T. Suda, N. Takahashi, N. Udagawa, and et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr. Rev. 20 1999 345 357
3. J. Xiong, M. Onal, R.L. Jilka, and et al. Matrix-embedded cells control osteoclast formation Nat. Med. 17 2011 1235 1241
4. T. Nakashima, M. Hayashi, T. Fukunaga, and et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression Nat. Med. 17 2011 1231 1234
5. H. Takayanagi, S. Kim, T. Koga, and et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Dev. Cell. 3 2002 889 901
6. B.F. Boyce, T. Yamashita, Z. Yao, and et al. Roles for NF-kappaB and c-Fos in osteoclasts J. Bone Min. Metab. 23 Suppl 2005 11 15
7. W.S. Simonet, D.L. Lacey, C.R. Dunstan, and et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
8. T. Ikeda, M. Utsuyama, and K. Hirokawa Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones J. Bone Min. Res. 16 2001 1416 1425
9. I. Kramer, S. Baertschi, C. Halleux, and et al. Mef2c deletion in osteocytes results in increased bone mass J. Bone Min. Res. 27 2012 360 373
10. M. Koide, Y. Kobayashi, T. Ninomiya, and et al. Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice Endocrinology 154 2013 773 782
11. C.Y. Logan, and R. Nusse The Wnt signaling pathway in development and disease Annu Rev. Cell. Dev. Biol. 20 2004 781 810
12. D.A. Glass 2nd, P. Bialek, J.D. Ahn, and et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation Dev. Cell. 8 2005 751 764
13. W. Wei, D. Zeve, X. Wang, and et al. Osteoclast progenitors reside in the peroxisome proliferator-activated receptor gamma-expressing bone marrow cell population Mol. Cell. Biol. 31 2011 4692 4705
14. K. Maeda, Y. Kobayashi, N. Udagawa, and et al. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis Nat. Med. 18 2012 405 412
15. S. Moverare-Skrtic, P. Henning, X. Liu, and et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures Nat. Med. 20 2014 1279 1288
16. B. Yu, J. Chang, Y. Liu, and et al. Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-kappaB Nat. Med. 20 2014 1009 1017
17. A. Mizuno, N. Amizuka, K. Irie, and et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin Biochem. Biophys. Res. Commun. 247 1998 610 615
18. T. Nakayama, T. Mizoguchi, S. Uehara, and et al. Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices-a simple method for identifying polarized osteoclasts Bone 49 2011 1331 1339
19. T. Yamane, T. Kunisada, H. Tsukamoto, and et al. Wnt signaling regulates hemopoiesis through stromal cells J. Immunol. 167 2001 765 772
20. A.O. Aliprantis, Y. Ueki, R. Sulyanto, and et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism J. Clin. Invest 118 2008 3775 3789
21. T. Ishitani, S. Kishida, J. Hyodo-Miura, and et al. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling Mol. Cell. Biol. 23 2003 131 139
22. L. Topol, X. Jiang, H. Choi, and et al. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation J. Cell. Biol. 162 2003 899 908
23. A. Sato, H. Yamamoto, H. Sakane, and et al. Wnt5a regulates distinct signalling pathways by binding to Frizzled2 EMBO J. 29 2010 41 54
24. K. Estrada, U. Styrkarsdottir, E. Evangelou, and et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture Nat. Genet. 44 2012 491 501
25. G. Hendrickx, E. Boudin, I. Fijalkowski, and et al. Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters Bone 59 2014 57 65
26. D.L. Koller, H.F. Zheng, D. Karasik, and et al. Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women J. Bone Min. Res. 28 2013 547 558
27. C. Medina-Gomez, J.P. Kemp, K. Estrada, and et al. Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus PLoS Genet. 8 2012 e1002718
28. R.L. van Bezooijen, B.A. Roelen, A. Visser, and et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist J. Exp. Med. 199 2004 805 814
29. R. Baron, and M. Kneissel WNT signaling in bone homeostasis and disease: from human mutations to treatments Nat. Med. 19 2013 179 192
30. J.M. Spatz, M.N. Wein, J.H. Gooi, and et al. The Wnt-inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in-vitro J. Biol. Chem. 2015 10.1074/jbc.M114.628313
31. M. Okamoto, N. Udagawa, S. Uehara, and et al. Noncanonical Wnt5a enhances Wnt/beta-catenin signaling during osteoblastogenesis Sci. Rep. 4 2014 4493